The company said in a statement that it wants patients in the US to only have access to "FDA-approved, safe, and effective" semaglutide products, adding: "These drugs are inherently complex to compound safely, and the risks they pose to patient safety far outweigh any benefits." The Alliance for Pharmacy Compounding (APC), a trade organisation representing the compounding industry, has claimed that Novo Nordisk is "confusing the fact that the semaglutide molecule is demonstrably difficult to manufacture [] with the relative simplicity of compounding with it," according to Reuters
Because GLP-1 medications slow gastric emptying, eating small but nutrient-rich snacks keeps you feeling more comfortable since theyre easier to digest
MetaboAnalyst: a web server for metabolomic data analysis and interpretation
For diabetics, Novo Nordisk currently markets semaglutide under the brand name Ozempic and as Wegovy for obesity
Must have good camera setup
Allie patiently explained the process and managed to fit me in just a few hours later